All In MedTech

Device Trial Radar · NCT07355270

A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)

Last checked: Nov 19, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Apr 1, 2026

Primary completion

Dec 31, 2026

Study completion Mar 31, 2027

Sponsor

Lead sponsor
Aqua Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jan 21, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety, tolerability and effectiveness of RF vapor ablation of the proximal intestinal mucosa. This study will test the hypothesis that RF vapor ablation will result in improvement in glycemic parameters, without Serious Adverse Events (SAE) or Unanticipated Adverse Device Effects (UADE).

Conditions

  • Type-2 Diabetes Mellitus

Interventions

  • RF Vapor AblationDevice

    RF Vapor ablation of the proximal intestinal mucosa

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety endpointTime frame: 6 months
  2. Tolerability endpointTime frame: 14 days
  3. Efficacy endpointTime frame: 6 months

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Mayo Clinic

    Scottsdale, Arizona · Recruiting

  • HonorHealth Research Institute

    Scottsdale, Arizona · Recruiting

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California · Recruiting

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.